Tai-Lung Cha, Ph.D.
Affiliations: | 2005 | The University of Texas Graduate School of Biomedical Sciences at Houston |
Area:
OncologyGoogle:
"Tai-Lung Cha"Parents
Sign in to add mentor| Mien-Chie Hung | grad student | 2005 | The University of Texas Graduate School of Biomedical Sciences at Houston | |
| (Targeting dysregulated nuclear proteins androgen receptor and enhancer of zeste homolog 2: Clinical implication and mechanism underline.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Tzeng SF, Tsai CH, Chao TK, et al. (2018) O-Glycosylation-mediated signaling circuit drives metastatic castration-resistant prostate cancer. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201800687 |
| Cha TL, Chuang MJ, Tang SH, et al. (2015) Emodin modulates epigenetic modifications and suppresses bladder carcinoma cell growth. Molecular Carcinogenesis. 54: 167-77 |
| Chuang MJ, Wu ST, Tang SH, et al. (2013) The HDAC inhibitor LBH589 induces ERK-dependent prometaphase arrest in prostate cancer via HDAC6 inactivation and down-regulation. Plos One. 8: e73401 |
| Cha TL, Zhou BP, Xia W, et al. (2005) Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3. Science (New York, N.Y.). 310: 306-10 |
| Rau KM, Kang HY, Cha TL, et al. (2005) The mechanisms and managements of hormone-therapy resistance in breast and prostate cancers. Endocrine-Related Cancer. 12: 511-32 |
| Cha TL, Qiu L, Chen CT, et al. (2005) Emodin down-regulates androgen receptor and inhibits prostate cancer cell growth. Cancer Research. 65: 2287-95 |